Abstract
The last decade has seen a dramatic increase in general interest in and research into vitamin D, with many athletes now taking vitamin D supplements as part of their everyday dietary regimen. The most recognized role of vitamin D is its regulation of calcium homeostasis; there is a strong relationship between vitamin D and bone health in non-athletic individuals. In contrast, data have consistently failed to demonstrate any relationship between serum 25 [OH]D and bone health, which may in part be due to the osteogenic stimulus of exercise. Vitamin D may interact with extra-skeletal tissues such as muscle and the immune system to modulate recovery from damaging exercise and infection risk. Given that many athletes now engage in supplementation, often consuming extreme doses of vitamin D, it is important to assess whether excessive vitamin D can be detrimental to health. It has been argued that toxic effects only occur when serum 25 [OH]D concentrations are greater than 180 nmolÁl -1 , but data from our laboratory have suggested high-dose supplementation could be problematic. Finally, there is a paradoxical relationship between serum 25 [OH]D concentration, ethnicity, and markers of bone health: Black athletes often present with low serum 25 [OH]D without physiological consequences. One explanation for this could be genetic differences in vitamin D binding protein due to ethnicity, resulting in greater concentrations of bioavailable (or free) vitamin D in some ethnic groups. In the absence of any pathology, screening may be unnecessary and could result in incorrect supplementation. Data must now be re-examined, taking into consideration bioavailable or ''free'' vitamin D in ethnically diverse groups to enable new thresholds and target concentrations to be established; perhaps, for now, it is time to ''set vitamin D free''.
A Brief Historical Perspective
Vitamin D was first identified in the early twentieth century by a forerunner of nutritional biochemistry, McCollum [1] . His pioneering work on experimental rickets was the first to identify the existence of a vitamin that was responsible for calcium deposition [1] , later called vitamin D. Primarily because of McCollum's work and the rickets epidemic of the same era, vitamin D was long recognized only for its role in bone health. Studies that followed determined the main source of vitamin D as ultraviolet B (UVB) radiation exposure and showed that limited quantities could be obtained from the diet alone. This highlighted that the vitamin D endocrine system likely developed as an evolutionary adaptation to the sun-rich environments in which humans evolved.
With advancement of new technologies, our understanding of the vitamin D endocrine system and its biological significance has grown exponentially. Generation of a vitamin D receptor knockout mouse [2] and highthroughput gene microarrays have provided a bounty of newly identified vitamin D targets in numerous tissues such as bone [3, 4] , immune system cells [5] , the cardiovascular system [6] , and skeletal muscle [7, 8] . Historically known & Graeme L. Close g.l.close@ljmu.ac.uk for its canonical role in mediating bone turnover, the validated functions of vitamin D are now understood to be much further reaching. Many of the newly identified functions of vitamin D have relevance for athletic performance and, as such, vitamin D has found the spotlight in the world of sports nutrition. Optimizing muscle function and remodeling, maintaining bone health, and minimizing infection risk are key examples of how vitamin D may benefit the athlete. However, vitamin D is clearly not an ergogenic aid but a biological requirement, and therefore the use of exogenous vitamin D in any population is a function of vitamin D status. This message has unfortunately been lost in the search for marginal gains. As we will uncover, the process of categorizing vitamin D concentrations has led to confusion, and new evidence suggests that such guidelines may indeed be based upon the measurement of the wrong form of vitamin D. The aim of this review is to provide a current perspective on the functions of vitamin D that may influence athletic performance, to clarify current guidelines for vitamin D intake, and to highlight crucial aspects of future work that must be tackled. We will address key areas of common confusion that surround vitamin D in the sports world, such as defining and measuring vitamin D and what physiological functions relevant to athletic performers can be optimized by maintenance of adequate vitamin D status.
What is Vitamin D Deficiency?
Exactly what constitutes vitamin D deficiency is subject to intense debate. Moreover, a lack of understanding of the key metabolites in the vitamin D pathway can lead to erroneous recommendations [9] . For this reason, we first present a collated overview of the US Institute of Medicine (IoM) guidelines for vitamin D classification [9] and a simplified schematic of the key vitamin D metabolites and sites of their production (Fig. 1) .
The IoM guidelines refer to concentrations of total serum 25 [12] .
It should also be considered that the US IoM reference intakes might be outdated. Recent commentaries clearly state that the IoM guidelines were developed based on the estimated average requirement (EAR) for vitamin D centered on its role in bone health [13] . Although the same authors state that extra-skeletal roles of vitamin D remain under study, a large evidence base of well-controlled trials suggests the regulation of bone turnover is but one functional role for vitamin D. At present, the most sensible approach is to avoid severe deficiency and concentrations considered toxic by the US IoM because the serum concentrations necessary to satisfy all biological needs with a vitamin D requirement is not yet fully understood.
More importantly, as we explore in more detail, the correlation between 25 [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] . Large variations exist between cohorts of non-supplemented athletes. For example, our laboratory has shown large variations between cohorts of elite rugby players, footballers, and jockeys [29] . Numerous factors, such as dietary differences, sunlight exposure, clothing, and lifestyle, may all contribute to the disparities [30] . It is important that athletes at risk of being deficient are tested before proceeding to correct the vitamin D inadequacy. It is crucial that applied practitioners and scientists are aware that whether athletes should be supplemented is purely based on whether they have sufficient or insufficient/deficient vitamin D concentrations. There is no ergogenic effect of providing doses of supplemental vitamin D that would elevate 25 [OH]D concentrations far above the cut-off for sufficiency ([75 nmolÁl -1 ). When a need to supplement has been identified, an appropriately screened supplemental form of vitamin D 3 should be sourced that can deliver the correct dose. Recommendations regarding supplementation dose vary widely and can often be confusing. From the authors' combined applied experience, dosing strategies for vitamin D in elite sport range from 1000 IU/day to blanket supplementation of up to a 100,000 IU bolus per week. This review should serve to direct practitioners towards a need for a supplementation decision system that should be implemented on an individual basis and provide the most current advice for safe and effective supplementation protocols.
Functional Roles of Vitamin D Relevant
to the Athlete
Muscle Repair and Remodeling
The purpose of athletic training is to provide a stimulus that disrupts homeostasis to bring about an adaptive response that improves competition performance. For athletes, maximizing the training stimulus is therefore a core principle of the training program. Nutrition strategies to with supplemental vitamin D 3 at 4000 IU/day has a positive effect on the recovery of force following a bout of damaging eccentric exercise [31] . Similar results were observed in correlative studies between serum 25[OH]D and force recovery following intense exercise [32, 33] . These results imply that adequate vitamin D exposure can optimize the acute adaptive response to damaging physical work but do not lend any support to the idea that vitamin D may be important over an extended period of training. However, a recent training study provided evidence to support this idea [34] . The authors supplemented 40 untrained young and elderly men with vitamin D 3 1920 IU (48 lg) ? 800 mg calcium per day during December-April (n = 20 per group), or calcium alone (placebo group) at a latitude of 56°N (very little sunlight exposure). During the final 12 weeks of the supplementation period, participants underwent a resistance training program for the quadriceps muscles. There were no observable differences between groups in strength gains or hypertrophy, but a great fiber type switch (more type IIA fibers) and a reduction in myostatin messenger RNA (mRNA) expression were observed in the young men receiving vitamin D. Interestingly, the elderly men receiving vitamin D showed an improvement in muscle quality above that of the placebo group. Taking in vivo data together, it appears that, where more drastic remodeling is required, perhaps with a requirement for satellite cell recruitment, vitamin D may exert more pronounced benefits in muscle.
To definitively infer that vitamin D interacts with muscle to modulate some aspects of muscle remodeling, molecular mechanisms are essential. More studies have focused on the molecular actions of vitamin D in muscle than have focused on translational study designs, so the challenge to the field remains to decipher the key vitamin D targets in play during the remodeling process. One study analyzed global gene expression profiles during mechanical overload-induced skeletal muscle hypertrophy in the adult mouse [35] . Interestingly, the vitamin D receptor (VDR)/retinoid X receptor (RXR) nuclear receptor-signaling pathway showed significant upregulation during the early stages of hypertrophy. Given the known protein interactions of the VDR (presented graphically in Fig. 2 ), it is clear that VDR signaling interacts with pathways associated with the maintenance of skeletal muscle mass. In particular, it may be postulated that VDR signaling is important for satellite cell activity, consistent with in vivo observations discussed earlier. Emerging experimental evidence is in support of this notion. First, the VDR is expressed in satellite cells and can regulate cell fate decisions (i.e., to differentiate or divide and maintain the stem cell pool) in satellite cell cultures [36] . Moreover, downregulation of the notch pathway, a key regulator of satellite cell activation [37] , has been reported in vitamin D-deficient myogenic cell cultures [38] . We have shown that the migration and fusion of human-derived skeletal muscle precursor cells is improved in the presence of 1,25[OH] 2 D 3 [31] . mRNA and protein expression of the VDR appears higher in satellite cells than in mature muscle fibers, suggesting a more prominent role in muscle progenitors [36] .
The signaling axes through which the VDR might mediate these effects are not well defined. However, the known and predicted VDR-interacting partners (presented in Fig. 2 ), such as mothers against decapentaplegic homolog 3 (smad3) (implicating the bone morphogenetic protein (BMP)/transforming growth factor (TGF)-b axis), Src (Proto-oncogene tyrosine-protein kinase Src)/phosphoinositide 3 kinase (PI3K), and cAMP responsible element-binding protein (CREB) cascades, are attractive candidates given their identified roles in muscle progenitor differentiation and regeneration of muscle following damage [39, 40] .
In summary, both large-scale gene expression trials and focused experimental studies performed in vitro and in vivo suggest that vitamin D has the capacity to influence skeletal muscle remodeling, which is of importance to the athletic performer. Future studies could use publicly available gene and protein array data to identify candidate pathways for validation, through which vitamin D may exert its effects in satellite cells and potentially mature skeletal muscle fibers.
Muscle Function
Whether vitamin D has the capacity to have any measurable effect on skeletal muscle function in young, trained athletes is debatable. Available data on this topic are limited and highly underpowered in young athletic populations. Moreover, the data that exist are mixed, with some reporting a positive effect of vitamin D [29, 41] and others reporting no effect [42, 43] . Many previous reviews discuss the role of vitamin D in muscle function of the athlete but discuss data from non-athletic populations. Athletes typically have minimal margins for improvement because they are highly trained. Thus, only directly observing effects in highly trained, athletic populations can give meaningful results that relate to high performance.
Assertions that vitamin D is important for muscle function may be due to consistently positive findings in elderly populations. By meta-analysis, it has been reported that a small number of studies demonstrate an increase in proximal muscle strength in adults with 25 [OH]D concentrations \25 nmolÁl -1 [44] . It may be that the sarcopenic status of elderly muscle permits more measurable benefits to be gleaned from the maintenance of adequate vitamin D concentration. Another theory is that muscle function may only be perturbed with severe vitamin D deficiency, which is more prevalent in the ageing population [45] .
It may be that vitamin D deficiency negatively impacts muscle function; however, data coupling cases of severe deficiency with muscle function in elite athletes do not exist. Therefore, at present it is not possible to suggest that vitamin D does play a role in the contractile properties and force-producing capacity of muscle in athletes. Large-scale RCTs are needed to address this question, and examination of athletes at the lowest end of vitamin D deficiency (\25 nmolÁl -1 ) is required.
Innate and Acquired Immunity
Vitamin D has been reported to play important roles in aspects of both innate and acquired immune function [46, 47] . As stated previously (Fig. 1) [48] . In the immune system specifically, vitamin D upregulates gene expression of broad-spectrum anti-microbial peptides (AMPs), which are important regulators in innate immunity [49, 50] . Vitamin D also exerts an immunomodulatory effect on T and B lymphocytes in acquired immunity [17, 46] . AMPs, including cathelicidin, are important proteins in the innate immune system [51] and help defend against acute illness, including tuberculosis, influenza, and the common cold [52] [53] [54] . Vitamin D is further suggested to maintain a balance between the inflammatory type 1 and type 17 T-helper (TH1/TH17) cells and the immunosuppressive Th2/regulatory T cells (Tregs) to dampen excessive inflammation and tissue damage [55] and modulate the acquired immune response. Additional studies suggest that vitamin D enhances natural killer cell cytolytic activity [56] and acts to trigger the oxidative burst in activated macrophages [57] . A single dose of vitamin D 3 (100,000 IU) has been shown to enhance the innate immune response and restrict growth of mycobacteria in vitro [57] .
Variations in vitamin D concentrations have the potential to measurably influence the immune response. A handful of studies in athletes [46, 58] , military personnel Vitamin D and the Athlete S7 [59] , and the general population [60] [61] [62] [64] . Athletes with low vitamin D concentrations also had higher URTI symptom days and higher symptom-severity scores. However, randomly assigned placebo-controlled studies are needed in athletic populations to confirm the effectiveness of correcting low vitamin D concentrations on aspects of immune health and the prevention of URTIs. One recent RCT in university athletes found evidence that 14-week supplementation with vitamin D 3 5000 IU per day during winter training significantly increased salivary secretion rates of cathelicidin and secretory immunoglobulin A compared with a placebo control, which could improve resistance to respiratory infections [65] .
Cardiac Structure and Function
The heart and vascular system, like skeletal muscle, contain the VDR and the apparatus for 1,25[OH] 2 D 3 production [66, 67] . An association between vitamin D concentration and cardiovascular function was first observed 30 years ago in Sprague-Dawley rats; histological analysis of vitamin D-deficient rats showed significantly smaller ventricular myofibrils and increases in extracellular matrix proteins compared with vitamin D-sufficient rats [67] . Subsequent research has established that vitamin D deficiency may adversely affect cardiac contractility, vascular tone, cardiac collagen content, and cardiac tissue maturation [68] .
Human trials have produced some evidence that vitamin D deficiency may be related to an increased risk of cardiometabolic outcomes. The Framingham Offspring Study found an association between lower serum 25 [OH]D concentrations and increased risk of cardiovascular events [50] . There was a graded increase in cardiovascular risk across pre-specified thresholds of 25 [73] . The relationship between vitamin D and cardiac function in the general population therefore remains controversial, with research generating equivocal evidence. The heterogeneity of research findings may be a consequence of differing definitions of vitamin D status, age of sample population, definition and determination of cardiovascular endpoints, and other confounding factors.
Professional athletes are unique amongst the general population, as they regularly participate in prolonged and intensive physical exercise that is associated with several structural and electrophysiological cardiac adaptations [74] . These adaptations enhance diastolic filling and facilitate a sustained increase in cardiac output, which is fundamental to athletic performance. Such cardiac adaptations are collectively referred to as the ''athlete's heart''. Numerous factors affect the adaptations of the athlete's heart, including sporting modality, duration and intensity, age, ethnicity, sex, anthropometry, and performance-enhancing substance abuse (Fig. 3) . Despite some evidence of a relationship between vitamin D and cardiac function, few studies have examined the association between 25 [OH]D concentration and cardiac structure and function in healthy athletes, a population repeatedly reported to be vitamin D deficient [22, 29, 75] . Our group recently observed that the aortic root and left atria diameters, intraventricular septum diameter, LV diameter during diastole, LV mass, LV volume during diastole, and right atrial area of severely 25 [OH]D-deficient (defined as \25 nmolÁl -1 ) athletes were significantly smaller than those of insufficient and sufficient athletes [76] .
The precise mechanisms causing this lack of cardiac hypertrophy in the 25[OH]D-deficient state remain unclear. However, what is understood, is that the remodeling mechanisms associated with cardiac disease and chronic overloading (such as long-standing mitral insufficiency, essential hypertension, chronic heart failure, kidney disease, and dilated cardiomyopathy) differ considerably from the physiological adaptations seen in athletes induced through prolonged and intensive exercise.
Studies in rodent models show that the VDR and 1a-hydroxylase mediate arterial hardening and endothelial function. Also, the endothelial dysfunction observed in VDR-knockout mice is caused by a reduction in nitric oxide bioavailability [77] . Furthermore, vitamin D induces a counter-regulatory process in the renin-angiotensin-aldosterone system by diminishing its proliferating effects on the vascular smooth muscle cells [78] . There may also be vitamin D-dependent cardio-protective mechanisms, including reducing vessel wall damage caused by inflammation through increased expression of anti-inflammatory cytokines, such as interleukin (IL)-10, and decreasing expression of pro-inflammatory molecules, e.g., tumor necrosis factor (TNF)-a and IL-6 [79] .
The relationship between vitamin D and cardiac function remains highly controversial. Despite the growing body of evidence demonstrating a link between vitamin D deficiency and cardiovascular risk factors, very few studies have examined the association between vitamin D status and cardiac structure and function in healthy athletes. Future research should look to identify the precise mechanisms causing cardiac hypertrophy with increases in vitamin D status in healthy athletes.
Bone Health and Fracture Risk
Vitamin D status is indicative of calcium absorption and bone mineralization [80] , and a considerable expanse of knowledge describes the relationship between vitamin D deficiency and bone health [80] [81] [82] [83] [84] [85] [86] [87] . Genetic, environmental, and cultural factors associated with 25 [OH]D deficiency [88] increase the risk of osteoporosis [89] and are a major contributor to fracture risk [90] . However, observational studies fail to universally affirm a proportionate susceptibility to bone loss, osteoporotic fractures, or rickets [91, 92] , particularly in athletes, a population in which stress fractures are frequently observed [93] .
Bone is a metabolically active tissue capable of adapting to mechanical stimuli and repairing structural damage [94] . Bone remodeling is a dynamic physiological process that consists of three main consecutive processes: (1) resorption, when osteoclasts digest old bone; (2) reversal, when mononuclear cells appear on the bone surface; and (3) formation, when osteoblasts lay down new bone until the resorbed bone is completely replaced [95] [96] [97] [98] , regulates phosphate homeostasis by increasing fibroblast growth factor 23 (FGF23) [99] , and may enhance the response of mechanical loads via stimulation of mitogen-activated protein kinase signaling [100] . Evidence now shows that bone cells can produce Fig. 3 Schematic representation of demographic (blue) and pathological (red) factors that may influence the cardiovascular adaptation to exercise [133] [101] .
Athletes undertake mechanical loading from training or competition that is associated with an increase in bone mineral density (BMD) [102, 103] . Any training-induced increase in body mass contributes to the process of bone remodeling and forms mechanically appropriate bone structure [104] . The stimulus of loading the musculoskeletal system through high-intensity dynamic sporting activity is proposed to compensate for 25 [OH]D deficiency, with the absence of poor bone health in athletes [102, 105] . However, non-weight-bearing athletes are prone to the same detrimental skeletal effects [104, 106] and are at higher risk for low BMD when vitamin D status is low [107] [108] [109] .
Recent research shows no association between serum 25[OH]D concentration and measures of bone health in an ethnically diverse athletic population, irrespective of exercise type (weight/non-weight bearing) [110] . This draws into question the use of 25 [OH]D concentration as a measure for predicting bone health in the athletic population. Genetic polymorphism in the 25 [OH]D/1,25[OH] 2 D pathway may potentially account for some of these differences [22, 111] . This notion is supported by recent research that demonstrated racial differences in manifestations for vitamin D and markers of bone health [112, 113] . Further detail on this phenomenon is described in Sect. 5 of this review.
Optimum concentrations of serum 25 [OH]D for the best possible skeletal health are still debated. Many investigators define the threshold for vitamin D sufficiency as the lowest serum 25 [OH]D concentration that maximally suppresses PTH secretion and/or optimizes BMD [114] [115] [116] . Observational studies have shown inconsistent associations between BMD and serum 25[OH]D status [117, 118] , particularly in racial minorities and athletic populations [113, 119, 120] . Further work, including controlled genetic studies, is needed to discriminate between direct actions of 1,25 [ [122] . VDBP is a 51-58 kDa multifunctional and highly polymorphic glycoprotein synthesized primarily by the hepatic parenchymal cells. Originally known as the group-specific component (Gc-globulin), VDBP is a member of a multigene family that includes albumin (Alb) and is a monomeric peptide of 458 residues and three disulphide-bonded, structural domains [123] . Two binding regions have been localized: (1) vitamin D-binding domain, located between residues 35-49 at the N-terminal and (2) actin-binding domain, positioned between residues 350-403 at the C-terminal. These are necessary to mediate VDBP cellular functions [124] (Fig. 4) [126] .
Genotyping has identified two common single-nucleotide polymorphisms (SNPs) in the coding region of the VDBP gene (rs4588 and rs7041) [127] . Combinations of these two SNPs produce three major polymorphic forms of VDBP (Gc1F, Gc1S, and Gc2), which differ substantially in their binding affinity for 25 [OH]D, circulating concentration, and variation between ethnic groups [128] and are in turn linked to VDBP function. These variants change the amino acid sequence, alter the protein function, and are common enough to generate population-wide constitutive differences in vitamin D status [50, 127] . Therefore, racial differences in manifestations of vitamin D deficiency may indeed be related to genetic variation in VDBP [128] . However, to date, research on vitamin D status in athletes has overlooked these common allelic variations in VDBP. These findings also question the relative importance of measuring total 25 [122] . However, the authors showed that Black subjects had levels of bioavailable 25 [OH]D similar to those of White subjects (2.9 ± 0.1 and 3.1 ± 0.1 ngÁml -1 , respectively), which may explain why Black subjects presented with consistently lower serum 25 [OH]D but higher BMD compared with White subjects [122] .
This questions the validity of the commonly used laboratory test for serum 25 [OH]D concentrations in assessing vitamin D deficiency in ethnically diverse groups. Consistent with the ''free hormone'' hypothesis [14] , several recent studies have shown that some functions of vitamin D may be more closely related to the free or bioavailable fraction of vitamin D than to total serum 25[OH]D concentrations. For instance, the bioavailable fraction of circulating 25 [OH]D was more strongly associated with BMD than the total levels in healthy adults [128] . Similar findings have been observed between bioavailable 25[OH]D and intact PTH, a marker of calcium balance related to bone health [130] . Emerging research also suggests that bioavailable vitamin D is a better predictor of BMD in an ethnically diverse athletic population than serum 25 [OH]D concentration [131] and may provide insight into why no universally accepted consensus for vitamin D levels currently exists. For practitioners who wish to measure bioavailable vitamin D, this has been reported to be The N-terminus refers to the start of a protein or polypeptide terminated by an amino acid with a free amine group (-NH 2 ). By convention, peptide sequences are written N-terminus to C-terminus [127] Vitamin D and the Athlete S11
performed by competitive radioligand-binding assay [128] and antibody-based assays [110] , which are commercially available laboratory kits. 
Conclusions
The emerging body of evidence surrounding vitamin D and athletic performance is bolstering support for the need to control vitamin D concentration in athletes. Undoubtedly, adverse risks are associated with vitamin D deficiency that will affect athletic performance directly and indirectly. New insights into the responses of the vitamin D metabolome to supplementation, and emerging evidence suggestive that free 25 [OH]D may be a more useful marker of vitamin D status, add new complexities to the area. Nevertheless, the field moves closer to a more complete understanding of the vitamin D endocrine system. The purpose of our review was to collate the most recent advances in this field and provide suggestions, based on current understanding, as to how vitamin D can be managed in practice. To this end, we have structured our thoughts into a decision tree (Fig. 5) that we believe will yield the most effective, safe protocols for those dealing with a broad range of athletes. We hope to inform the field that blanket approaches to supplementation, mega doses of vitamin D, bolus doses of vitamin D, and lack of consideration for an individualized approach should be avoided.
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